4528 — Ono Pharmaceutical Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapContrarian

Annual income statement for Ono Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	292,420	309,284	361,361	447,187	502,672
Cost of Revenue
Gross Profit	213,357	223,711	267,850	337,125	375,546
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	214,929	210,809	257,921	305,224	342,737
Operating Profit	77,491	98,475	103,440	141,963	159,935
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	79,696	100,890	105,025	143,532	163,734
Provision for Income Taxes
Net Income After Taxes	59,888	75,498	80,685	112,913	128,040
Minority Interest
Net Income Before Extraordinary Items
Net Income	59,704	75,426	80,519	112,723	127,978
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	59,704	75,425	80,519	112,708	127,964
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	118	151	173	243	267
Dividends per Share